Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

The cAMP pathway and the control of adrenocortical development and growth.

de Joussineau C, Sahut-Barnola I, Levy I, Saloustros E, Val P, Stratakis CA, Martinez A.

Mol Cell Endocrinol. 2012 Mar 31;351(1):28-36. doi: 10.1016/j.mce.2011.10.006. Epub 2011 Oct 15. Review.

2.

How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?

Almeida MQ, Stratakis CA.

Mol Cell Endocrinol. 2011 Apr 10;336(1-2):162-8. doi: 10.1016/j.mce.2010.11.018. Epub 2010 Nov 25. Review.

3.

cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors.

Rosenberg D, Groussin L, Bertagna X, Bertherat J.

Endocr Res. 2002 Nov;28(4):765-75.

PMID:
12530696
4.

Cortisol-secreting adrenocortical tumours in dogs and their relevance for human medicine.

Galac S.

Mol Cell Endocrinol. 2016 Feb 5;421:34-9. doi: 10.1016/j.mce.2015.06.026. Epub 2015 Jun 27. Review.

PMID:
26123587
5.

Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease.

Bourdeau I, Stratakis CA.

Ann N Y Acad Sci. 2002 Jun;968:240-55. Review.

PMID:
12119280
6.

Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.

de Cremoux P, Rosenberg D, Goussard J, Brémont-Weil C, Tissier F, Tran-Perennou C, Groussin L, Bertagna X, Bertherat J, Raffin-Sanson ML.

Endocr Relat Cancer. 2008 Jun;15(2):465-74. doi: 10.1677/ERC-07-0081.

7.

Inhibins and activins: their roles in the adrenal gland and the development of adrenocortical tumors.

Hofland J, de Jong FH.

Mol Cell Endocrinol. 2012 Aug 15;359(1-2):92-100. doi: 10.1016/j.mce.2011.06.005. Epub 2011 Jun 22. Review.

PMID:
21722704
8.

Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).

Tadjine M, Lampron A, Ouadi L, Horvath A, Stratakis CA, Bourdeau I.

Clin Endocrinol (Oxf). 2008 Sep;69(3):367-73. doi: 10.1111/j.1365-2265.2008.03273.x. Epub 2008 Apr 14.

9.

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.

Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J.

J Clin Endocrinol Metab. 2008 Oct;93(10):4135-40. doi: 10.1210/jc.2008-0631. Epub 2008 Jul 22.

PMID:
18647815
10.

Protein kinase A alterations in adrenocortical tumors.

Espiard S, Ragazzon B, Bertherat J.

Horm Metab Res. 2014 Nov;46(12):869-75. doi: 10.1055/s-0034-1385908. Epub 2014 Aug 8. Review.

PMID:
25105543
11.

mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).

de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, Tauveron I, Pointud JC, Lefrançois-Martinez AM, Stratakis CA, Bertherat J, Val P, Martinez A.

Hum Mol Genet. 2014 Oct 15;23(20):5418-28. doi: 10.1093/hmg/ddu265. Epub 2014 May 27.

12.

Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.

Heyerdahl SL, Boikos S, Horvath A, Giatzakis C, Bossis I, Stratakis CA.

Horm Metab Res. 2008 Jun;40(6):391-7. doi: 10.1055/s-2008-1058089. Epub 2008 Mar 6.

PMID:
18401830
13.
14.

Primary pigmented nodular adrenocortical disease and Cushing's syndrome.

Horvath A, Stratakis C.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1238-44. Review.

15.

Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.

Hofland J, de Herder WW, Derks L, Hofland LJ, van Koetsveld PM, de Krijger RR, van Nederveen FH, Horvath A, Stratakis CA, de Jong FH, Feelders RA.

Eur J Endocrinol. 2012 Dec 10;168(1):67-74. doi: 10.1530/EJE-12-0594. Print 2013 Jan.

16.

cAMP signaling in cortisol-producing adrenal adenoma.

Calebiro D, Di Dalmazi G, Bathon K, Ronchi CL, Beuschlein F.

Eur J Endocrinol. 2015 Oct;173(4):M99-106. doi: 10.1530/EJE-15-0353. Epub 2015 Jul 2. Review.

17.

Transcription factor 3',5'-cyclic adenosine 5'-monophosphate-responsive element-binding protein (CREB) is decreased during human adrenal cortex tumorigenesis and fetal development.

Rosenberg D, Groussin L, Jullian E, Perlemoine K, Medjane S, Louvel A, Bertagna X, Bertherat J.

J Clin Endocrinol Metab. 2003 Aug;88(8):3958-65.

PMID:
12915693
20.

Unraveling the molecular basis of micronodular adrenal hyperplasia.

Horvath A, Stratakis CA.

Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):227-33. doi: 10.1097/MED.0b013e3282fe7416. Review.

Supplemental Content

Support Center